Purilogics® develops novel membrane adsorbers for biologics purification. Unlike other high capacity membrane products, PurexaTM membrane products are differentiated by their tentacle based ion-exchange ligands.

As part of the Small Business Innovative Research (SBIR) program, the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Purilogics with a grant to commercialize affinity membrane adsorbers for purification of influenza vaccines.

Purilogics is excited to attend ACS Spring 2019 in Orlando. We would love to talk shop about your purification challenges! Come visit us at our posters 6-8pm April 2nd to see the latest data on our multimodal anion exchange and Protein A membrane chromatography prototypes.